These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10416749)

  • 1. The Hettinger hand vibration test, vasospasm, and glaucoma.
    Goldberg I; Chai E; Chia A; Benscher C; Bauman A; Chen J
    Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S66-78. PubMed ID: 10416749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual field responses to a hand vibration stimulus.
    Chai E; Goldberg I; Chia A; Chen J
    Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S79-86. PubMed ID: 10416750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blocker eyedrops and nocturnal arterial hypotension.
    Hayreh SS; Podhajsky P; Zimmerman MB
    Am J Ophthalmol; 1999 Sep; 128(3):301-9. PubMed ID: 10511024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol. Brimonidine Study Groups 1 and 2.
    Schuman JS
    Ophthalmology; 2000 Jun; 107(6):1171-7. PubMed ID: 10857839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary open-angle glaucoma patients characterized by ocular vasospasm demonstrate a different ocular vascular response to timolol versus betaxolol.
    Evans DW; Harris A; Cantor LB
    J Ocul Pharmacol Ther; 1999 Dec; 15(6):479-87. PubMed ID: 10609770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Combination Glaucoma Therapies on β-Blocker Exposure.
    Xu K; Campbell EL; Gill SS; Nesdole R; Campbell RJ
    J Glaucoma; 2017 Feb; 26(2):e107-e109. PubMed ID: 28059862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nocturnal arterial hypotension in optic nerve head ischemic disorders.
    Hayreh SS; Podhajsky P; Zimmerman MB
    Ophthalmologica; 1999; 213(2):76-96. PubMed ID: 9885384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The favorable effect of topical betaxolol and timolol on glaucomatous visual fields: a 2-year follow-up study.
    Vainio-Jylhä E; Vuori ML
    Graefes Arch Clin Exp Ophthalmol; 1999 Feb; 237(2):100-4. PubMed ID: 9987624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of beta-blockers on ocular blood flow in patients with primary open angle glaucoma: a color Doppler imaging study.
    Altan-Yaycioglu R; Türker G; Akdöl S; Acunaş G; Izgi B
    Eur J Ophthalmol; 2001; 11(1):37-46. PubMed ID: 11284483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timolol increased retrobulbar flow velocities in untreated glaucoma eyes but not in ocular hypertension.
    Bergstrand IC; Heijl A; Wollmer P; Hansen F; Harris A
    Acta Ophthalmol Scand; 2001 Oct; 79(5):455-61. PubMed ID: 11594978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of betaxolol and dorzolamide effect on ocular circulation in normal-tension glaucoma patients.
    Harris A; Arend O; Chung HS; Kagemann L; Cantor L; Martin B
    Ophthalmology; 2000 Mar; 107(3):430-4. PubMed ID: 10711877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longterm effect of topical beta-blockers on intraocular pressure and visual field sensitivity in ocular hypertension and chronic open-angle glaucoma.
    Collignon-Brach J
    Surv Ophthalmol; 1994 May; 38 Suppl():S149-55. PubMed ID: 7940136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
    Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
    Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dorzolamide timolol combination versus timolol 0.5% on ocular bloodflow in patients with primary open-angle glaucoma.
    Harris A; Jonescu-Cuypers CP; Kagemann L; Nowacki EA; Garzozi H; Cole C; Martin B
    Am J Ophthalmol; 2001 Oct; 132(4):490-5. PubMed ID: 11589868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative evaluation of the hypotensive effectiveness of beta blockers].
    Erichev VP
    Vestn Oftalmol; 1992; 108(3):25-7. PubMed ID: 1362302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta-blockers in the treatment of open-angle glaucoma].
    Potocký M; Vodrázková E
    Cesk Slov Oftalmol; 1996 Nov; 52(6):399-402. PubMed ID: 9072217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucoma.
    Watson PG; Barnett MF; Parker V; Haybittle J
    Br J Ophthalmol; 2001 Aug; 85(8):962-8. PubMed ID: 11466256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis of circulatory disorders in the optic nerve in primary open-angle glaucoma. Communication 2. New technologies for the imaging and evaluation of the circulatory system in the optic nerve head].
    Kharlap SI; Kozlova IV; Vashkulatova EA
    Vestn Oftalmol; 2009; 125(6):59-64. PubMed ID: 20143546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.
    Brooks AM; Gillies WE
    Drugs Aging; 1992; 2(3):208-21. PubMed ID: 1351412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optic nerve head morphology in primary open-angle glaucoma and nonarteritic anterior ischaemic optic neuropathy measured with spectral domain optical coherence tomography.
    Resch H; Mitsch C; Pereira I; Schwarzhans F; Wasserman L; Hommer A; Reitner A; Vass C
    Acta Ophthalmol; 2018 Dec; 96(8):e1018-e1024. PubMed ID: 30240137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.